Efficacy of the Combination of Amlodipine and Valsartan in Patients With Hypertension Uncontrolled With Previous Monotherapy: The Exforge in Failure After Single Therapy (EX-FAST) Study
Article first published online: 10 APR 2008
2008 Le Jacq
The Journal of Clinical Hypertension
Volume 10, Issue 3, pages 185–194, March 2008
How to Cite
Allemann, Y., Fraile, B., Lambert, M., Barbier, M., Ferber, P. and Izzo, J. L. (2008), Efficacy of the Combination of Amlodipine and Valsartan in Patients With Hypertension Uncontrolled With Previous Monotherapy: The Exforge in Failure After Single Therapy (EX-FAST) Study. The Journal of Clinical Hypertension, 10: 185–194. doi: 10.1111/j.1751-7176.2008.07516.x
- Issue published online: 10 APR 2008
- Article first published online: 10 APR 2008
- Manuscript received July 25, 2007; revised October 25, 2007; accepted October 25, 2007
- 17Two multicenter, 8-week, randomized, double-blind placebo controlled, parallel-group studies evaluating the efficacy and tolerability of amlodipine and valsartan in combination and as monotherapy in adult patients with mild to moderate essential hypertension. Clin Ther. 2007;29:563–580., , , et al.
- 19Clinical events in high-risk hypertensive patients randomly assigned to calcium channel blocker versus angiotensin-converting enzyme inhibitor in the antihypertensive and lipid-lowering treatment to prevent heart attack trial. Hypertension. 2006;48:374–384., , , et al.
- 23Initial angiotensin-converting enzyme inhibitor/calcium channel blocker combination therapy achieves superior blood pressure control compared with calcium channel blocker monotherapy in patients with stage 2 hypertension. Am J Hypertens. 2004;17:495–501., , , et al.